Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 1,230 | 1,164 | 1,425 | 1,630 | 1,794 | 1,748 | 1,712 | 1,912 |
| Operating profit | €m | 161 | 172 | ||||||
| Net profit | €m | -37 | 44 | 57 | 38 | 56 | 140 | 164 | 132 |
| EPS reported | € | 3.01 | 3.52 | ||||||
| Operating cashflow per share | € | 3.83 | 3.75 | ||||||
| Capex per share | € | 2.20 | 2.30 | ||||||
| FCF per share | € | 1.62 | 1.45 | ||||||
| Free cash flow | €m | 74.0 | 66.6 | ||||||
| Net debt | €m | 123 | 265 | ||||||
| Book value equity | €m | 1,085 | 1,141 | ||||||
| Book value per share | € | 23.37 | 24.42 | ||||||
| Number of shares | m | 46.42 | 46.71 | ||||||
| DPS (TTM paid) | € | 0.46 | 0.46 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 17.64 | - | ||||||
| P/B LTM | x | 2.23 | 2.35 | ||||||
| P/S LTM | x | 1.39 | 1.57 | ||||||
| P/FCF LTM | x | 32.76 | 40.28 | ||||||
| EV/EBITDA LTM | x | 10.47 | 11.40 | ||||||
| EV/Sales LTM | x | 1.52 | 1.72 | ||||||
| Earnings Yield LTM | % | 5.67% | 6.06% | ||||||
| FCF Yield | % | 3.05% | 2.48% | ||||||
| Quality | |||||||||
| ROE | % | 12.88% | 14.71% | ||||||
| ROIC | % | 6.72% | 7.17% | ||||||
| Operating margin | % | 9.21% | 10.02% | ||||||
| Gross margin | % | 6.91% | 8.13% | ||||||
| FCF/Sales | % | 4.23% | 3.89% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +150.83% | +160.74% | ||||||
| Sales Growth YoY | % | -2.57% | -8.62% | ||||||
| Net Income Growth YoY | % | +149.48% | +160.01% | ||||||
| FCF Growth | % | -7.54% | -16.31% | ||||||
| Operating Profit Growth | % | +75.13% | +11.96% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.74% | 0.78% | ||||||
| Dividend Growth | % | +17.95% | +17.95% | ||||||
| Payout Ratio | % | 12.81% | 12.81% | ||||||
| FCF/Debt | x | 0.15 | 0.13 | ||||||
| Net Debt/EBITDA | x | 0.92 | 1.03 | ||||||
| EBIT/Net interest | x | 1.98 | 2.22 | ||||||
| Net debt/market cap | % | 5.08% | 9.88% | ||||||
| Net debt/Equity | x | 0.11 | 0.23 | ||||||
| Gross debt/equity | x | 0.46 | 0.45 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free